Collection of Philadelphia-negative peripheral blood progenitor cells in unselected patients with chronic granulocytic leukaemia

Leukemia

Volumn 12, Issue 5, 1998, Pages 746-752

  Lennard, A L ^a   Storey, N ^a   Dickinson, A M ^a   Irving, J A ^a   Rowe, D ^b   Conn, J S ^a   Proctor, S J ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

Chronic granulocytic leukaemia; Peripheral blood progenitor cells; Unselected patients

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN; CYTARABINE; DAUNORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYUREA; PREDNISOLONE; VINCRISTINE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CELL SELECTION; CHROMOSOME ANALYSIS; CHRONIC GRANULOCYTIC LEUKEMIA; COLONY FORMING UNIT GM; DISEASE COURSE; FEMALE; GENE EXPRESSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; LEUKAPHERESIS; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0031897480     PISSN: 08876924     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.leu.2400993     Document Type: Article

References (14)

1. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M. Chronic myelogenous leukaemia: a concise update. Blood 1993; 82: 691-703.
2. Camplin R, McGlave PB. Allogeneic bone marrow transplantation for chronic myeloid leukemia. In: Forman SJ, Blume KG, Thomas ED (eds). Bone Marrow Transplantation. Blackwell Scientific Publications: Boston, MA, 1994, pp 595-606.
3. Clift RA, Applebaum FR, Thomas ED. Treatment of chronic myeloid leukemia by bone marrow transplantation. Blood 1993; 82: 1954-1956.
4. Taylor PRA, Ross JRY, Gorst DW. Population based study of allogeneic marrow transplant versus conventional treatment in chronic myeloid leukaemia, in four Regional Health Districts in the UK. Br J Haematol 1994; 86: 27 (Abstr.).
5. Kantarjian HM, Smith TL, O'Brien S, Beran M, Pierce S, Talpaz M. Prolonged survival in chronic myelogenous leukemia after cytogenetic response to interferon-alpha therapy. Ann Intern Med 1995; 122: 254-261.
6. The Italian Cooperative Study Group. Myeloid leukemia interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. New Engl J Med 1994; 330: 820-825.
7. Allan NC, Richards SM, Shepherd PCA. UK Medical Research Council randomised, multicentre trial of interferon-alpha-n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. Lancet 1996; 345: 1392-1397.
8. Coulombel L, Kalousek DK, Eaves CJ, Gupta CM, Eaves AC. Long-term marrow culture reveals chromosomally normal hemopoietic progenitor cells in patients with Philadelphia chromosome-positive chronic myeloid leukemia. New Engl J Med 1983; 308: 1493-1497.
9. Barnett MJ, Eaves CJ, Phillips GL, Gascoyne RD, Hogge DE, Horsman DE, Humphries RK, Klingemann H, Lansdorf PM, Mantel SH, Reece DE, Shepherd JD, Spinelli JJ, Sutherland HJ, Eaves AC. Auto-grafting with cultured marrow in chronic myeloid leukemia: results of a pilot study. Blood 1994; 84: 724-732.
10. Brito-Babapulle F, Bowcock SJ, Marcus RE, Apperley J, Th'ng KH, Dowding C, Guo A, Catovsky D, Gallon DAG, Goldman JM. Autografting for patients with chronic myeloid leukaemia in chronic phase: peripheral blood stem cells may have a finite capacity for maintaining haemopoiesis. Br J Haematol 1989; 73: 76-81.
11. Kantarjian HM, Talpaz M, LeMaistre CF et al. Intensive combination chemotherapy and autologous bone marrow transplantation leads to the reappearance of Philadelphia chromosome negative cells in chronic myeloid leukemia. Cancer 1991; 67: 2959-2965.
12. McGlave PB, De Fabritiis P, Deisseroth A, Goldmann J, Barnett M, Reiffers J, Simonsson B, Carella A, Aeppli D. Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groups. Lancet 1994; 343: 1486-1488.
13. Carella AM, Podesta M, Frassoni F, Raffo MR, Pollicardo N, Pungolino E, Vimercati R, Sessarego M, Parodi C, Rabitti C, Ferrero R, Benvenuto F, Figari O, Carlier P, Levcasic G, Valbonesi M, Vitale V, Giordano D, Pierluigi, D, Nati S, Guerracio A, Rosso C, Saglio G. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in chronic myelogenous leukemia. Bone Marrow Transplant 1993; 12: 267-271.
14. Carella AM, Frassoni F, Podesta M, Pungolino E, Pollicardo N, Ferrero R, Soracco M. Idarubicin, intermediate-dose cytarabine, etoposide, and granulocyte colony-stimulating factor are able to recruit CD34+/HLA-DR- cells during early hematopoietic recovery in accelerated and chronic phases of chronic myeloid leukemia. J Hematother 1994; 3: 199-202.